| pubmed-article:19998639 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C1138603 | lld:lifeskim |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C0279025 | lld:lifeskim |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C0033080 | lld:lifeskim |
| pubmed-article:19998639 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:19998639 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:19998639 | pubmed:dateCreated | 2009-12-10 | lld:pubmed |
| pubmed-article:19998639 | pubmed:abstractText | This study examined patient and provider characteristics associated with being prescribed an aromatase inhibitor (AI) vs tamoxifen-only therapy among a cohort of postmenopausal North Carolina Medicaid enrollees diagnosed with hormone receptor-positive breast cancer. | lld:pubmed |
| pubmed-article:19998639 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19998639 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19998639 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19998639 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19998639 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19998639 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19998639 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19998639 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19998639 | pubmed:issn | 0027-9684 | lld:pubmed |
| pubmed-article:19998639 | pubmed:author | pubmed-author:PaskettElectr... | lld:pubmed |
| pubmed-article:19998639 | pubmed:author | pubmed-author:BalkrishnanRa... | lld:pubmed |
| pubmed-article:19998639 | pubmed:author | pubmed-author:KimmickGretch... | lld:pubmed |
| pubmed-article:19998639 | pubmed:author | pubmed-author:AndersonRoger... | lld:pubmed |
| pubmed-article:19998639 | pubmed:author | pubmed-author:McLaughlinJoh... | lld:pubmed |
| pubmed-article:19998639 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19998639 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:19998639 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19998639 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19998639 | pubmed:pagination | 1112-8 | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:meshHeading | pubmed-meshheading:19998639... | lld:pubmed |
| pubmed-article:19998639 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19998639 | pubmed:articleTitle | Patient and provider determinants associated with the prescription of adjuvant hormonal therapies following a diagnosis of breast cancer in Medicaid-enrolled patients. | lld:pubmed |
| pubmed-article:19998639 | pubmed:affiliation | Division of Epidemiology, College of Public Health, Ohio State University, Columbus, Ohio, USA. | lld:pubmed |
| pubmed-article:19998639 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19998639 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19998639 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
